The global market for medical imaging reagents was valued at USD 10.3 billion in 2012 and is expected to reach USD 18.5 billion in 2019
According
a market report published by Transparency Market Research, U.S.-based
market intelligence firm, the global medical imaging reagents market
was estimated to be worth USD 10.3 billion in 2012, and is expected
to reach an estimated value of USD 18.5 billion in 2019, growing at
an 8.8% CAGR during the period.
To
browse through the ToC or purchase the medical imaging reagents
market report, please visit:
http://www.transparencymarketresearch.com/biologic-imaging-reagents-market.html
The
report, titled “Medical Imaging Reagents Market (Class: Contrast
Reagents, Optical Reagents and Nuclear Reagents; Technology:
Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes,
Radiopharmaceuticals and Quantum Dots & Application: Diagnostics,
Drug Discovery and Development and Research and Development) - Global
Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 –
2019” attributes the escalation of the industry to the rise in the
number of cardiovascular and cancer patients worldwide.
Medical
imaging reagents are chemicals that enhance images generated by
imaging devices. They help in locating metastatic cancerous sites in
the body and also help in ascertaining if a tumor is benign or
malignant. Reagents play a key role in healthcare segments such as
life sciences, biotechnology medical, pharmaceuticals and diagnostics
Information
provided by the Union for International Cancer Control (UICC) states
that over the next 20 years, nearly 25 million people will be
diagnosed with cancer, almost 75% more than the current number. This
would lead to an increasing demand for medical imaging modalities
which would subsequently raise the demand for medical imaging
reagents. Moreover, as highlighted in the TMR report, the growing
geriatric population is also expected to propel the market,
accompanied by the advancement in diagnostic technology.
The
market restraints, as mentioned in the report, are inflexible
regulatory approvals, hesitation in adopting nuclear products, and
short supply of imaging reagents.
Get
Sample Report Copy From here :
The
research report has primarily segmented the global medical imaging
reagents market based on technology, class, applications and
geography.
- Technology: This can be further categorized into
- fluorescent particles,
- nanoparticles,
- radiopharmaceuticals,
- fluorescent dyes and probes,
- and quantum dots.
- On the basis of class, the market is fragmented into
- nuclear reagents,
- contrast reagents
- optical reagents
- Applications: The applications segment consists of
- diagnostics
- drug discovery and development
- and research and development
Related Market Research Report :
Global liver diseases therapeutics market :
Global Car Rental Market :
- Geography: Region-wise the industry is divided into
- North America,
- Asia-Pacific,
- Europe
- Rest of the World.
The
contrast reagents segment of the market made up the largest share,
while nuclear agents are expected to witness the highest growth rate
among all, registering a 14% rise from 2103 to 2019. Among the
technologies, radiopharmaceuticals accounted for the largest market
share, with nanoparticles technology growing at the fastest rate of
9.1%. Among the applications, diagnostic application enjoyed the
biggest market share, with an estimated value of USD 10 billion by
2019. Geographically, North America accounted for nearly 40% of the
total market share in 2012, followed by Europe.
Some
of the major industry players mentioned in the report include Bracco
Imaging SpA, Bayer Healthcare AG, GE Healthcare, Becton Dickinson &
Company, Lantheus Medical Imaging Inc., Thermo Fisher Scientific
Inc., Siemens Healthcare and Mallinckrodt Pharmaceuticals.
Browse
More Pharmaceuticals Market Research Reports :
No comments:
Post a Comment